FDA 483 - Accupack Midwest Inc - February 27, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Accupack Midwest Inc. in Cincinnati, OH, revealed four repeat observations concerning the manufacturing of OTC drug products. The firm was cited for lacking written procedures for component sampling and water system monitoring, failing to qualify critical equipment and water systems, and not validating production processes. Additionally, issues with equipment cleaning and contamination prevention were noted, indicating significant deficiencies in their quality control systems.
ID · a3ae9c5d-df93-4e6e-8353-e958d806b159